Pharmaceuticals
Jobs at Eisai
About Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
- Industry
- Pharmaceuticals
- Open roles
- 69
Open positions
Explore roles at Eisai
Showing 50 of 69 roles
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.
Eisai
Eisai is a pharmaceutical company focused on neurology and oncology, with a strong emphasis on research and development, including the development of treatments for Alzheimer’s disease.